Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data Packages

IMPORTANCE: The pharmaceutical industry has made substantial investments in developing processes for sharing individual-participant data (IPD) from clinical trials. However, the utility and completeness of shared IPD and supporting documents must be evaluated to ensure the potential for scientific a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hopkins, Ashley M., Modi, Natansh D., Abuhelwa, Ahmad Y., Kichenadasse, Ganessan, Kuderer, Nicole M., Lyman, Gary H., Wiese, Michael D., McKinnon, Ross A., Rockhold, Frank W., Mann, Aaron, Rowland, Andrew, Sorich, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557028/
https://www.ncbi.nlm.nih.gov/pubmed/37796495
http://dx.doi.org/10.1001/jamaoncol.2023.3996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557028/
https://www.ncbi.nlm.nih.gov/pubmed/37796495
http://dx.doi.org/10.1001/jamaoncol.2023.3996

Ejemplares similares